SE0101327D0 - New crystalline forms - Google Patents
New crystalline formsInfo
- Publication number
- SE0101327D0 SE0101327D0 SE0101327A SE0101327A SE0101327D0 SE 0101327 D0 SE0101327 D0 SE 0101327D0 SE 0101327 A SE0101327 A SE 0101327A SE 0101327 A SE0101327 A SE 0101327A SE 0101327 D0 SE0101327 D0 SE 0101327D0
- Authority
- SE
- Sweden
- Prior art keywords
- oxa
- crystalline forms
- ylüethylcarbamate
- tert
- butyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Priority Applications (32)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0101327A SE0101327D0 (sv) | 2001-04-12 | 2001-04-12 | New crystalline forms |
TW091106493A TWI237025B (en) | 2001-04-12 | 2002-04-01 | New crystalline forms of antiarrhythmic compounds |
ARP020101189A AR035452A1 (es) | 2001-04-12 | 2002-04-02 | Sales farmaceuticamente aceptables de compuestos antiarritmicos, procedimiento para la preparación de estas sales, formulación farmaceutica y el uso de estos compuestos para la manufactura de medicamentos para el uso en la profilaxis o el tratamiento de una arritmia |
SK1257-2003A SK12572003A3 (sk) | 2001-04-12 | 2002-04-12 | Farmaceutická kompozícia obsahujúca 3,7-diazabicyklo [3.3.1]-deriváty ako účinnú zložku a jej použitie |
DK02761972T DK1389213T3 (da) | 2001-04-12 | 2002-04-12 | 3,7-Diazabicyclo[3.3.1]formuleringer som antiarytmiske forbindelser |
EP05007851A EP1550663A1 (en) | 2001-04-12 | 2002-04-12 | New crystalline forms of antiarrhythmic compounds |
RU2003129231/04A RU2286993C2 (ru) | 2001-04-12 | 2002-04-12 | 3,7-диазабицикло[3.3.1]-препараты как антиаритмические соединения |
PCT/SE2002/000725 WO2002083688A1 (en) | 2001-04-12 | 2002-04-12 | 3,7-diazabicyclo [3.3.1] formulations as antiarhythmic compounds |
PT02761972T PT1389213E (pt) | 2001-04-12 | 2002-04-12 | Formulacoes de 3,7-diazabiciclo 3,3,1¿ como compostos antiarritmicos |
ES02761972T ES2261721T3 (es) | 2001-04-12 | 2002-04-12 | Formulaciones de 3,7-diazabiciclo(3.3.1) como compuestos antiarritmicos. |
EEP200300504A EE200300504A (et) | 2001-04-12 | 2002-04-12 | 3,7-diasabitsüklo[3.3.1]preparaadid, nende valmistamise meetod ja nimetatud preparaatide kasutaminesüdame arütmiate profülaktikas või ravis |
HU0303487A HUP0303487A3 (en) | 2001-04-12 | 2002-04-12 | Compositions containing 3,7-diazabicyclo [3,3,1] compounds as anthiarhythmic agents and process for preparation of the compounds |
NZ528560A NZ528560A (en) | 2001-04-12 | 2002-04-12 | 3,7-diazabicyclo [3.3.1] formulations as antiarrhythmic compounds |
PL02367179A PL367179A1 (en) | 2001-04-12 | 2002-04-12 | 3,7-diazabicyclo [3.3.1] formulations as antiarhythmic compounds |
US10/474,592 US7217708B2 (en) | 2001-04-12 | 2002-04-12 | 3,7-Diazabicyclo [3.3.1] formulations as anti-arrhythmic compounds |
CA002443470A CA2443470A1 (en) | 2001-04-12 | 2002-04-12 | 3,7-diazabicyclo [3.3.1] formulations as antiarhythmic compounds |
EP02761972A EP1389213B1 (en) | 2001-04-12 | 2002-04-12 | 3,7-diazabicyclo 3.3.1| formulations as antiarhythmic compounds |
SI200230325T SI1389213T1 (sl) | 2001-04-12 | 2002-04-12 | 3,7-diazabiciklo(3.3.1)formulacije kot antiaritmicne spojine |
KR10-2003-7013320A KR20030087078A (ko) | 2001-04-12 | 2002-04-12 | 항부정맥 화합물로서의 3,7-디아자비시클로[3.3.1] 조성물 |
MXPA03009206A MXPA03009206A (es) | 2001-04-12 | 2002-04-12 | FORMULACIONES DE 3,7-DIAZABICICLO [3.3.1] COMO COMPUESTOS ANTIARRiTMICOS. |
AT02761972T ATE323095T1 (de) | 2001-04-12 | 2002-04-12 | 3,7-diazabicycloc3.3.1)-formulierungen als antiarrhythmika |
JP2002581443A JP2004525970A (ja) | 2001-04-12 | 2002-04-12 | 抗不整脈化合物としての3,7−ジアザビシクロ[3.3.1]製剤 |
CNB028116283A CN1269823C (zh) | 2001-04-12 | 2002-04-12 | 作为抗心律不齐化合物的3,7-二氮杂双环[3.3.1]制剂 |
BR0208829-0A BR0208829A (pt) | 2001-04-12 | 2002-04-12 | Sal farmaceuticamente aceitável, composto, processos para a preparação de um sal, de um composto e de uma forma cristalina dos compostos, formulação farmacêutica, uso de um composto, e, método de profilaxia ou tratamento de uma arritmia |
DE60210598T DE60210598T2 (de) | 2001-04-12 | 2002-04-12 | 3,7-DIAZABICYCLOc3.3.1Ü-FORMULIERUNGEN ALS ANTIARRHYTHMIKA |
CZ20032760A CZ20032760A3 (cs) | 2001-04-12 | 2002-04-12 | Farmaceutická kompozice obsahující 3,7-diazabicyklo[3.3.1]-deriváty jako účinnou složku a její použití |
IL15825002A IL158250A0 (en) | 2001-04-12 | 2002-04-12 | 3,7-diazabicyclo [3.3.1] formulations as antiarrhythmic compounds |
UA2003098709A UA74629C2 (en) | 2001-04-12 | 2002-12-04 | A derivative of 3,7-diazabicyclo [3,3,1] compounds , pharmaceutically acceptable salts thereof, a method for producing and composition based thereon as antiarrhythmic agents |
ZA200307759A ZA200307759B (en) | 2001-04-12 | 2003-10-03 | 3,7-diazabicyclo[3.3.1]formulations as antiarrhythmic compounds. |
IS6980A IS6980A (is) | 2001-04-12 | 2003-10-08 | 3,7-díasabísýkló [3.3.1] blöndur sem efnasambönd gegn sláttarglöpum |
NO20034527A NO20034527L (no) | 2001-04-12 | 2003-10-09 | 3,7-diazabicyklo(3,3,1) formuleringer som antiarytmiforbindelser |
HK04104077A HK1061026A1 (en) | 2001-04-12 | 2004-06-08 | 3,7-Diazabicyclo 3.3.1Ü formulations as antiarhythmic compounds |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0101327A SE0101327D0 (sv) | 2001-04-12 | 2001-04-12 | New crystalline forms |
Publications (1)
Publication Number | Publication Date |
---|---|
SE0101327D0 true SE0101327D0 (sv) | 2001-04-12 |
Family
ID=20283783
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE0101327A SE0101327D0 (sv) | 2001-04-12 | 2001-04-12 | New crystalline forms |
Country Status (30)
Country | Link |
---|---|
US (1) | US7217708B2 (et) |
EP (2) | EP1550663A1 (et) |
JP (1) | JP2004525970A (et) |
KR (1) | KR20030087078A (et) |
CN (1) | CN1269823C (et) |
AR (1) | AR035452A1 (et) |
AT (1) | ATE323095T1 (et) |
BR (1) | BR0208829A (et) |
CA (1) | CA2443470A1 (et) |
CZ (1) | CZ20032760A3 (et) |
DE (1) | DE60210598T2 (et) |
DK (1) | DK1389213T3 (et) |
EE (1) | EE200300504A (et) |
ES (1) | ES2261721T3 (et) |
HK (1) | HK1061026A1 (et) |
HU (1) | HUP0303487A3 (et) |
IL (1) | IL158250A0 (et) |
IS (1) | IS6980A (et) |
MX (1) | MXPA03009206A (et) |
NO (1) | NO20034527L (et) |
NZ (1) | NZ528560A (et) |
PL (1) | PL367179A1 (et) |
PT (1) | PT1389213E (et) |
RU (1) | RU2286993C2 (et) |
SE (1) | SE0101327D0 (et) |
SK (1) | SK12572003A3 (et) |
TW (1) | TWI237025B (et) |
UA (1) | UA74629C2 (et) |
WO (1) | WO2002083688A1 (et) |
ZA (1) | ZA200307759B (et) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI259836B (en) * | 2001-04-12 | 2006-08-11 | Astrazeneca Ab | Modified release formulation suitable for antiarrhythmic compounds |
SE0401539D0 (sv) * | 2004-06-15 | 2004-06-15 | Astrazeneca Ab | New compounds |
SE0401540D0 (sv) * | 2004-06-15 | 2004-06-15 | Astrazeneca Ab | New compounds |
AR057064A1 (es) * | 2005-06-13 | 2007-11-14 | Astrazeneca Ab | Compuestos para el tratamiento de arritmias cardiacas, formulacion farmaceutica y preparacion del compuesto |
MX2007016496A (es) * | 2005-06-20 | 2008-03-06 | Astrazeneca Ab | Proceso para la preparacion de oxabispidinas n-n' -disustituidas. |
AR053901A1 (es) * | 2005-06-20 | 2007-05-23 | Astrazeneca Ab | Formas fisicas de oxabispidinas n,n'- disustituidas |
TW200734342A (en) * | 2005-12-15 | 2007-09-16 | Astrazeneca Ab | New compounds for the treatment of cardiac arrhythmias |
CA2644613A1 (en) * | 2006-03-07 | 2007-09-13 | Endacea, Inc. | Compositions and methods for treating respiratory disorders |
JP5113838B2 (ja) | 2006-06-26 | 2013-01-09 | アケビア セラピューティックス, インコーポレイテッド | プロリルヒドロキシラーゼ阻害剤および使用方法 |
MX2013014310A (es) | 2011-06-06 | 2014-01-23 | Akebia Therapeutics Inc | Compuestos y composiciones para estabilizar el factor-2 alfa inducible por hipoxia como un metodo para tratar el cancer. |
NO2686520T3 (et) | 2011-06-06 | 2018-03-17 | ||
SG11201509998WA (en) | 2013-06-13 | 2016-01-28 | Akebia Therapeutics Inc | Compositions and methods for treating anemia |
TW201946625A (zh) | 2013-11-15 | 2019-12-16 | 美商阿克比治療有限公司 | {[5-(3-氯苯基)-3-羥基吡啶-2-羰基]胺基}乙酸之固體型式,其組合物及用途 |
WO2016118858A1 (en) | 2015-01-23 | 2016-07-28 | Akebia Therapeutics, Inc. | Solid forms of 2-(5-(3-fluorophenyl)-3-hydroxypicolinamido)acetic acid, compositions, and uses thereof |
DK3277270T3 (da) | 2015-04-01 | 2021-12-06 | Akebia Therapeutics Inc | Sammensætninger og fremgangsmåder til behandling af anæmi |
CN112088155A (zh) | 2018-05-09 | 2020-12-15 | 阿克比治疗有限公司 | 用于制备2-[[5-(3-氯苯基)-3-羟基吡啶-2-羰基]氨基]乙酸的方法 |
US11524939B2 (en) | 2019-11-13 | 2022-12-13 | Akebia Therapeutics, Inc. | Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino} acetic acid |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3732094A1 (de) * | 1987-09-24 | 1989-04-06 | Basf Ag | Bispidinderivate als klasse iii-antiarrhythmika |
US5110933A (en) * | 1989-11-13 | 1992-05-05 | Board Of Regents Of Oklahoma State University | Salts of 3-azabicyclo[3.3.1]nonanes as antiarrhythmic agents, and precursors thereof |
SE9704709D0 (sv) * | 1997-12-17 | 1997-12-17 | Astra Ab | Pharmaceutically active compounds |
SE9902268D0 (sv) | 1999-06-16 | 1999-06-16 | Astra Ab | Pharmaceutically active compounds |
SE9903759D0 (sv) * | 1999-10-18 | 1999-10-18 | Astra Ab | Pharmaceutically active compounds |
-
2001
- 2001-04-12 SE SE0101327A patent/SE0101327D0/xx unknown
-
2002
- 2002-04-01 TW TW091106493A patent/TWI237025B/zh not_active IP Right Cessation
- 2002-04-02 AR ARP020101189A patent/AR035452A1/es not_active Application Discontinuation
- 2002-04-12 JP JP2002581443A patent/JP2004525970A/ja active Pending
- 2002-04-12 EP EP05007851A patent/EP1550663A1/en not_active Withdrawn
- 2002-04-12 SK SK1257-2003A patent/SK12572003A3/sk not_active Application Discontinuation
- 2002-04-12 WO PCT/SE2002/000725 patent/WO2002083688A1/en active IP Right Grant
- 2002-04-12 HU HU0303487A patent/HUP0303487A3/hu unknown
- 2002-04-12 PT PT02761972T patent/PT1389213E/pt unknown
- 2002-04-12 CN CNB028116283A patent/CN1269823C/zh not_active Expired - Fee Related
- 2002-04-12 RU RU2003129231/04A patent/RU2286993C2/ru not_active IP Right Cessation
- 2002-04-12 CA CA002443470A patent/CA2443470A1/en not_active Abandoned
- 2002-04-12 MX MXPA03009206A patent/MXPA03009206A/es active IP Right Grant
- 2002-04-12 US US10/474,592 patent/US7217708B2/en not_active Expired - Fee Related
- 2002-04-12 EE EEP200300504A patent/EE200300504A/et unknown
- 2002-04-12 CZ CZ20032760A patent/CZ20032760A3/cs unknown
- 2002-04-12 DE DE60210598T patent/DE60210598T2/de not_active Expired - Fee Related
- 2002-04-12 IL IL15825002A patent/IL158250A0/xx unknown
- 2002-04-12 KR KR10-2003-7013320A patent/KR20030087078A/ko not_active Application Discontinuation
- 2002-04-12 NZ NZ528560A patent/NZ528560A/en unknown
- 2002-04-12 AT AT02761972T patent/ATE323095T1/de not_active IP Right Cessation
- 2002-04-12 BR BR0208829-0A patent/BR0208829A/pt not_active IP Right Cessation
- 2002-04-12 PL PL02367179A patent/PL367179A1/xx unknown
- 2002-04-12 ES ES02761972T patent/ES2261721T3/es not_active Expired - Lifetime
- 2002-04-12 DK DK02761972T patent/DK1389213T3/da active
- 2002-04-12 EP EP02761972A patent/EP1389213B1/en not_active Expired - Lifetime
- 2002-12-04 UA UA2003098709A patent/UA74629C2/uk unknown
-
2003
- 2003-10-03 ZA ZA200307759A patent/ZA200307759B/en unknown
- 2003-10-08 IS IS6980A patent/IS6980A/is unknown
- 2003-10-09 NO NO20034527A patent/NO20034527L/no not_active Application Discontinuation
-
2004
- 2004-06-08 HK HK04104077A patent/HK1061026A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE0101327D0 (sv) | New crystalline forms | |
EA200300717A1 (ru) | Гетероциклилиндазольные и -азаиндазольные соединения в качестве 5-гидрокситриптамин-6-лигандов | |
IS6565A (is) | Trópan afleiður nytsamlegar í meðferð | |
DE60216233D1 (en) | Carbolinderivate | |
SI1392642T1 (sl) | Nove spojine kot protivnetna, imunomodulacijska in antiproliferativna sredstva | |
DK0527036T3 (da) | 4-Benzoylisoxazolderivater og deres anvendelse som herbicider | |
DE60121461D1 (de) | Kondensierte pyridoindolderivate | |
ATE494893T1 (de) | Sulfonamide, sulfamate und sulfamide als gamma- secretase-hemmer | |
DE602004027490D1 (de) | Indazol-, benzisoxazol- und benzisothiazol-kinaseinhibitoren | |
ATE302775T1 (de) | Carbolinderivate | |
ATE481093T1 (de) | Vervendung von dexrazoxane in der prävention und behandlung der alzeheimer-krankheit | |
BR0209149A (pt) | Ftalazinonas | |
MXPA03009750A (es) | Compuestos quimicos. | |
MXPA02012076A (es) | Compuestos quimicos. | |
MXPA02012659A (es) | Derivados de pirazindiona condensados. | |
ATE356130T1 (de) | Inhibitoren von cruzipain und anderen cysteinproteasen | |
SE0400043D0 (sv) | New compounds | |
BR0017157A (pt) | Derivados de 6-hidroxi-indazol para o tratamento de glaucoma | |
ATE302776T1 (de) | Kondensierte pyridoindolderivate | |
NO995963D0 (no) | Karboksamider anvendelige som 5-HTIF-agonister | |
ATE333457T1 (de) | Zyklische gmp-spezifische phosphodiesteraseinhibitoren | |
AR030756A1 (es) | Compuesto de oxabispidina util en el tratamiento de arritmias cardiacas | |
BR9813719A (pt) | Agentes terapêuticos | |
DE60121048D1 (de) | PYRAZINOi1'2':1,6öPYRIDOi3,4-BöINDOLDERIVATE | |
ATE293111T1 (de) | Kondensierte pyrazindionderivate als pde inhibitoren |